Felbinac

This classification denotes a nonsteroidal antiinflammatory drug with the molecular formula C14H12O2, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier 94WNJ5U8L7, chemically known as ljc 10,141 but generally known as felbinac, which bears US NIH Compound Identifier 3332. European Medicines Agency schedules Felbinac in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB07527MIG. The term FELBINAC is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 40, No. 6, 1986, List 26). World Health Organization schedules felbinac in its Anatomical Therapeutic Chemical (ATC) Classification. FELBINAC is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule felbinac under HS 29163900 and SITC 51379. As of Q4 2014, FELBINAC remains the US FDA Preferred Term for this commodity. Felbinac bears US NLM identifiers UMLS ID C0877860 and NCI Concept Code C80546. SMILES: OC(=O)CC1CCC(C2CCCCC2)CC1.